Treatment With PEGASYS(R)/COPEGUS(TM) Provides Hope For Hepatitis C Patients Whose Infection Did Not



 
Treatment With PEGASYS(R)/COPEGUS(TM) Provides Hope For Hepatitis C Patients Whose Infection Did Not


Roche announced final results from the REPEAT study, which demonstrated that treatment with once-weekly PEGASYS(R) (peginterferon alfa-2a) and daily COPEGUS(TM) (ribavirin) for 72 weeks is a promising treatment option for patients whose infection did not respond to previous treatment with another pegylated interferon (Peg- Intron(R), peginterferon alfa-2b) and ribavirin. [click link for full article]

read more...

News entry number 3002 added on Nov 4, 2007 in the Health category.

Comenteaza  

Rating: 0.00 (din 5)
Voturi 0

Adauga Rating


Other News in the Health category
Categorie:

Categorie:

Categorie:

Categorie:

Categorie:


Related Links



News Categories


Top 10 News

Statistics

News:
News Categories:
News Read:
5039
8
622